Analystreport

Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.25 price target on the stock.

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com